We observed that the cytotoxic effect of PARP and XIAP inhibition, administered in a sequential combination regimen was superior to PARP inhibition alone in downregulating survival and inducing apoptosis in BRCA proficient BC cell lines. Here, PARP1 is linked to breast cancer.